Biorbis Antibody Engineering and Design Conference and Workshops
Antibody Engineering and Design USA
Accelerating Progress in Antibody Drug Development
Conference: July 28th/29th 2010 | Pre-conference Workshops: July 27th | Boston, Massachusetts, USA
Official Partners
Immunologix, Inc.
Immunologix delivers on a key unmet need, in fully realizing the vast clinical and market potential of antibody-based therapeutics. Utilizing a proprietary in vitro method, exclusively licensed from the Medical University of South Carolina, Immunologix is uniquely positioned to derive countless fully-human antibody-based therapeutics specific for virtually any known biological target. No other known technology platform can produce fully-human antibodies using a 100% in vitro system.
Web: www.immunologix.com
Genovis.
Web: www.genovis.com
Precision Antibody
Precision Antibody provides customized, high-affinity monoclonal antibodies to pharmaceutical and biotechnology companies for use in discovery, research, and testing of novel pharmaceuticals, biomarkers, and diagnostic tests. The company’s services are based on a proprietary antibody discovery and development platform technology that enables rapid development of target-specific, high-affinity antibodies. Precision Antibody provides one-stop service for antibody development, characterization (affinity determination by Biacore), purification/production (from pilot to large scale), and conjugation, as well as hybridoma cell banking.
